Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB

Q: What does this research mean for the field?

A shortened 9-month oral regimen for rifampicin- or multidrug-resistant tuberculosis is effective, safe, and improves patient-reported outcomes. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

E. Herrera-Flores; E. Shen; Dante E. Vargas-Vasquez; Félix Konrad Llanos-Tejada; Z. Ruiz-Vargas; J. Cornejo-García; D. Vela-Trejo; Z.M. Puyen-Guerra; M.C. Rojas; D.M. Guerra; M.L. Romo; J. Jimenez; Elna Osso; Letizia Trevisi; A. LaHood; M.L. Rich; KJ Seung; CD Mitnick; MF Franke; L. Lecca; V. Alarcon-Guizado

doi:10.5588/ijtldopen.25.0553

Key Points

To evaluate the effectiveness and safety of a shortened oral regimen for treating rifampicin- and multidrug-resistant TB.
Conducted a 9-month treatment regimen
Monitored safety and effectiveness
Assessed patient-reported outcomes
The regimen was effective in treating TB
Patient-reported outcomes improved
Results support broader adoption in national TB programmes

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

A 9-month oral regimen shows improved outcomes in patients with multidrug-resistant TB, suggesting broader program adoption.

Abstract

This 9-month oral regimen was effective and safe and improved patient-reported outcomes. These results support broader adoption in national TB programmes across Latin America and beyond.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Herrera-Flores et al. (2026) studied this question.

synapsesocial.com/papers/69be36e36e48c4981c676123 https://doi.org/10.5588/ijtldopen.25.0553

View Full Paper

Ask AI

Bookmark

Share

Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading